28/11/2022

Abemaciclib and pembrolizumab in HR+/HER2- metastatic breast cancer

21/11/2022

How to select patients with breast and ovarian cancer for the treatment with olaparib

14/11/2022

Talazoparib as monotherapy in advanced breast cancer

09/11/2022

Olaparib shows promising results in early breast cancer

31/10/2022

Trastuzumab deruxtecan in HER2+ breast cancer with brain metastases

24/10/2022

Clinical benefits of an early therapeutic targeting of ESR1 mutation

17/10/2022

Treatment selection with genomics for metastatic breast cancer

10/10/2022

Pembrolizumab as post-nephrectomy adjuvant therapy in renal cell carcinoma

03/10/2022

Neoadjuvant immunotherapy as a promising approach in melanoma and colon cancer